Thymoquinone (TQ) is the primary bioactive compound found in the essential oil of black cumin seeds (Nigella sativa). Classified as a quinone, with the chemical name 5-isopropyl-2-methyl-1,4-benzoquinone, it’s responsible for a large portion of the biological activity that has made black cumin one of the most widely studied medicinal plants in the world. Its molecular formula is C₁₀H₁₂O₂, and it weighs just 164.20 grams per mole, making it a relatively small molecule with outsized interest from researchers investigating anti-inflammatory, antioxidant, and anticancer properties.
Where Thymoquinone Comes From
Thymoquinone is extracted from the seeds of Nigella sativa, a flowering plant in the buttercup family commonly called black cumin or black seed. The seeds are rich in alkaloids, proteins, saponins, and both fixed and volatile essential oils. TQ is the dominant compound in the volatile oil fraction, and it drives much of the therapeutic reputation that black cumin has built across centuries of traditional use and, more recently, in laboratory and clinical research.
Most commercially available thymoquinone comes in the form of cold-pressed black cumin seed oil, though the concentration of TQ in these oils varies significantly. Standard cold-pressed oils often contain relatively low amounts, which is why clinical trials have historically required high doses of oil (3 to 10 mL per day) to deliver a meaningful amount of the compound. Newer concentrated formulations, some containing 12 to 14.5% thymoquinone by analysis, allow for smaller serving sizes.
How It Works in the Body
Thymoquinone’s best-understood mechanism involves shutting down key inflammatory signaling chains inside cells. Research published in Scientific Reports demonstrated that TQ directly suppresses a signaling enzyme called IRAK1, which sits near the top of a cascade that activates two major inflammatory switches in cells. When those switches flip on, they trigger the production of inflammation-driving proteins, including enzymes that generate pain and swelling signals and nitric oxide, a molecule involved in chronic inflammatory damage.
By blocking IRAK1, thymoquinone prevents the chain reaction from getting started. In lab studies using immune cells exposed to bacterial toxins, TQ reduced both the phosphorylation (activation) of key signaling proteins and the downstream production of inflammatory molecules like nitric oxide and prostaglandin E2. In animal models, this translated to measurable protection against gastric injury and liver inflammation.
Antioxidant Effects
Beyond tamping down inflammation, thymoquinone boosts the body’s own antioxidant defenses. In cell studies, TQ increased the activity of catalase, an enzyme that breaks down hydrogen peroxide before it can damage cells. It also raised levels of superoxide dismutase (SOD) in both the cell’s main compartment and its mitochondria, the energy-producing structures particularly vulnerable to oxidative stress. At the genetic level, TQ upregulated a gene called GPX1, which codes for glutathione peroxidase, by more than 20-fold in one breast cancer cell line.
At the same time, TQ decreased the generation of hydrogen peroxide itself, meaning it works on both sides of the equation: reducing the production of damaging molecules while strengthening the enzymes that neutralize them. This dual action is part of what makes thymoquinone attractive as a potential therapeutic compound rather than a simple free-radical scavenger.
Anticancer Research
Much of the excitement around thymoquinone centers on its behavior in cancer cell studies. TQ appears to kill cancer cells through a combination of mechanisms. It arrests the cell cycle, essentially freezing cancer cells at checkpoints where they can no longer divide. In studies on bone cancer cells, TQ reduced the number of cells actively copying their DNA and increased the number stuck at the G1 checkpoint, the earliest decision point before a cell commits to division.
TQ also triggers apoptosis, the programmed self-destruction sequence that healthy cells use to remove themselves when they’re damaged but that cancer cells typically disable. It does this in part by increasing reactive oxygen species inside cancer cells and activating stress-response pathways that push the cell toward death. It’s worth noting that this research has been conducted primarily in cell cultures and animal models. Human clinical trials specifically testing thymoquinone as a cancer treatment are still limited, and no one should treat it as a substitute for established cancer therapies.
Metabolic Health Benefits
Some of the most promising human-relevant data involves metabolic health. In animal studies using diet-induced obese mice, thymoquinone at 20 mg per kilogram of body weight per day lowered fasting blood glucose, reduced fasting insulin levels, and improved both glucose tolerance and insulin sensitivity. Notably, TQ had no significant effect on these measures in lean animals eating a low-fat diet, suggesting it specifically targets the metabolic dysfunction caused by excess dietary fat rather than altering normal glucose regulation.
Human trials using black cumin seed oil (the whole oil, not isolated TQ) have shown similar trends. In one randomized study, a TQ-rich oil taken at 3 grams per day for 12 weeks produced significant reductions in body weight, BMI, fasting blood glucose, glycated hemoglobin (a marker of long-term blood sugar control), triglycerides, LDL cholesterol, and insulin resistance. Another trial found that 500 mg of cold-pressed oil taken twice daily for 8 weeks improved inflammation markers, oxidative stress, fasting glucose, and lipid profiles in people with type 2 diabetes. A separate trial using the same dose and duration showed improvements in cardiac health markers.
Other clinical findings include improved asthma control scores with 500 mg twice daily for 8 weeks, reduced liver fat and improved cholesterol ratios in people with non-alcoholic fatty liver disease given 2.5 mL of oil every 12 hours for 3 months, and better kidney function markers in people with chronic kidney disease supplementing 2.5 mL per day for 12 weeks.
The Bioavailability Problem
Thymoquinone’s biggest practical limitation is that the body has trouble absorbing it. TQ is highly lipophilic, meaning it dissolves well in fats but poorly in water, with an aqueous solubility of less than 1 mg per mL. Because the gut needs compounds to dissolve in its watery environment before absorption can occur, much of an oral dose of thymoquinone passes through without ever reaching the bloodstream.
Once absorbed, the compound has a relatively short plasma half-life of about 2.5 hours after oral administration (roughly 5 hours when given intravenously). The liver and kidneys are the primary organs that process and clear it, with eventual excretion largely through urine. This combination of poor absorption and fast clearance means that standard black cumin oil delivers only a fraction of its thymoquinone content to the tissues where it could be useful.
Researchers are working on advanced delivery systems to solve this. Lipid-polymer hybrid nanoparticles, for example, achieved a 4.74-fold increase in oral bioavailability compared to a conventional TQ suspension in animal studies. Other approaches include lipid-based nanocarriers and mucoadhesive formulations designed to stick to the intestinal lining and extend absorption time. These technologies are still largely experimental, but they represent the direction the field is moving.
Safety and Dosing
Preclinical toxicity studies following international safety guidelines established an upper safe limit of 900 mg of thymoquinone-rich black cumin oil per adult per day, corresponding to no more than 50 mg of isolated thymoquinone per adult per day. A Phase I safety trial tested 200 mg per day of a concentrated TQ-rich oil for 90 days in healthy subjects without raising safety concerns.
Most clinical trials have used whole black cumin seed oil rather than isolated thymoquinone, at doses ranging from 500 mg to 3 grams per day for periods of 6 to 12 weeks. These doses have generally been well tolerated. However, the wide variation in TQ concentration across different oil products means that “500 mg of black cumin oil” from one brand could deliver a very different amount of thymoquinone than the same volume from another. If you’re considering supplementation, the TQ percentage listed on the label (when available) matters more than the total oil volume.

